Drug Approval | July 22, 2024
Rusan Pharma’s API plant in Ankleshwar receives USFDA GMP approval
Rusan’s API facility in Ankleshwar is GMP approved by other stringent international agencies as well
Rusan’s API facility in Ankleshwar is GMP approved by other stringent international agencies as well
Diroximel Fumarate Delayed-Release Capsules is indicated for the treatment of relapsing forms of multiple sclerosis
Azilsartan Medoxomil and Chlorthalidone Tablets had annual sales of US$ 77.9 mn in the United States (IQVIA MAT March 24).
Theophylline is used to treat asthma and chronic obstructive pulmonary disease
Zydus is among the first suppliers to launch the generic version of Mirabegron Extended-Release Tablets, USP 25 mg in the US market
These facilities are commissioned by Aurobindo's wholly own subsidiary: Lyfius Pharma Private Limited, Qule Pharma Private Limited, Eugia Steriles Private Limited and Auroactive Pharma Private Limited.
USFDA inspects Zydus Lifesciences’ Ahmedabad SEZ Onco manufacturing plant
Letermovir tablets, 240 mg and 480 mg had annual sales of USD 289.5 mn in the United States (IQVIA MAT Jan-24)
The drug will be manufactured at the group’s formulation manufacturing facility at Ahmedabad SEZ II, India
Isosorbide mononitrate is used to prevent chest pain (angina) in patients with a certain heart condition (coronary artery disease)
Subscribe To Our Newsletter & Stay Updated
